We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ERFSF market cap is 10.23B. The company's latest EPS is EUR 2.1038 and P/E is 23.63.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 5.44B | 6.72B | 6.71B | 6.54B | 6.95B |
| Operating Income | 802.1M | 1.26B | 917.1M | 530.2M | 681M |
| Net Income | 539.4M | 782.6M | 610.2M | 310.2M | 406M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 8.58B | 9.33B | 10.08B | 10.89B | 10.89B |
| Total Liabilities | 4.86B | 4.66B | 5.23B | 5.75B | 5.5B |
| Total Equity | 3.72B | 4.68B | 4.85B | 5.14B | 5.39B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 1.22B | 1.51B | 1.14B | 1.02B | 1.32B |
| Investing | -525M | -1.03B | -855.9M | -681M | -846M |
| Financing | -48.6M | -910.4M | -311.3M | 413.4M | -1.09B |
| Market Cap | 10.23B |
| Price to Earnings Ratio | 23.63 |
| Price to Sales Ratio | 1.38 |
| Price to Cash Ratio | 15.63 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 192.98M |
| Average Volume (1 week) | 368 |
| Average Volume (1 Month) | 1.07k |
| 52 Week Change | -10.74% |
| 52 Week High | 68.45 |
| 52 Week Low | 44.61 |
| Spread (Intraday) | 5.98 (10.69%) |
| Company Name | Eurofins Scientific SA (PK) |
| Address |
23 val fleuri grand duche du L-1526 |
| Website | https://www.eurofins.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
